BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34819374)

  • 41. Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.
    Ho WS; Wang H; Maggio D; Kovach JS; Zhang Q; Song Q; Marincola FM; Heiss JD; Gilbert MR; Lu R; Zhuang Z
    Nat Commun; 2018 May; 9(1):2126. PubMed ID: 29844427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy.
    Xu L; Xu W; Jiang Z; Zhang F; Chu Y; Xiong S
    Cancer Biol Ther; 2009 Jan; 8(1):66-72. PubMed ID: 19029829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
    Matoba T; Imai M; Ohkura N; Kawakita D; Ijichi K; Toyama T; Morita A; Murakami S; Sakaguchi S; Yamazaki S
    Int J Cancer; 2019 Jun; 144(11):2811-2822. PubMed ID: 30485427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-Cell Analysis Reveals Characterization of Infiltrating T Cells in Moderately Differentiated Colorectal Cancer.
    Yang X; Qi Q; Pan Y; Zhou Q; Wu Y; Zhuang J; Xu J; Pan M; Han S
    Front Immunol; 2020; 11():620196. PubMed ID: 33584715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
    Xu T; Sun BC; Li Q; Hao XS
    World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
    Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
    Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
    Hasim MS; Marotel M; Hodgins JJ; Vulpis E; Makinson OJ; Asif S; Shih HY; Scheer AK; MacMillan O; Alonso FG; Burke KP; Cook DP; Li R; Petrucci MT; Santoni A; Fallon PG; Sharpe AH; Sciumè G; Veillette A; Zingoni A; Gray DA; McCurdy A; Ardolino M
    Sci Adv; 2022 Apr; 8(15):eabj3286. PubMed ID: 35417234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment.
    Li J; Jie HB; Lei Y; Gildener-Leapman N; Trivedi S; Green T; Kane LP; Ferris RL
    Cancer Res; 2015 Feb; 75(3):508-518. PubMed ID: 25480946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections.
    Rosenits K; Keppler SJ; Vucikuja S; Aichele P
    Eur J Immunol; 2010 Dec; 40(12):3450-7. PubMed ID: 21080375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
    J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trogocytosis-based generation of suppressive NK cells.
    Caumartin J; Favier B; Daouya M; Guillard C; Moreau P; Carosella ED; LeMaoult J
    EMBO J; 2007 Mar; 26(5):1423-33. PubMed ID: 17318190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    Qiao G; Qin J; Kunda N; Calata JF; Mahmud DL; Gann P; Fu YX; Rosenberg SA; Prabhakar BS; Maker AV
    Cancer Res; 2017 Apr; 77(8):1880-1891. PubMed ID: 28249900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation.
    Caudana P; Núñez NG; De La Rochere P; Pinto A; Denizeau J; Alonso R; Niborski LL; Lantz O; Sedlik C; Piaggio E
    Cancer Immunol Res; 2019 Mar; 7(3):443-457. PubMed ID: 30651291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells.
    Eisenberg G; Uzana R; Pato A; Frankenburg S; Merims S; Yefenof E; Ferrone S; Peretz T; Machlenkin A; Lotem M
    J Immunol; 2013 Jun; 190(11):5856-65. PubMed ID: 23626012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.
    Salem M; Wallace C; Velegraki M; Li A; Ansa-Addo E; Metelli A; Kwon H; Riesenberg B; Wu B; Zhang Y; Guglietta S; Sun S; Liu B; Li Z
    Cancer Res; 2019 Mar; 79(6):1178-1190. PubMed ID: 30674536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG; Lysaght J; Todryk S; Mills KH
    J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
    Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
    PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.